Taysha Gene Therapies Inc (TSHA)
R&D Expense Growth
30.91%
Fiscal year · Period ending:
TSHA R&D Expense Growth
Latest reported30.91%period ending
Latest reported30.91%period ending
TSHA FY R&D Growth (YoY) (0.00% → 30.91%)
Latest values, visible window
High-resolution chart · PNG
TSHA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 30.9117% | |
| 16.244% | |
| -37.7223% | |
| -30.9027% | |
| 313.7052% | |
| 3,131.307% | |
| 0% |